AVI BIOPHARMA, INC.

Company

Sarepta Therapeutics, Inc.

Filed

January 21, 2005

Accession Number

0000902664-05-000103

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →